SERA Feb 2025 7.500 call
- PR Newswire
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the H.C. Wainwright Global Investment Conference on Wednesday, September 11, 2024 at 10:00 a.m. ET. Zhenya Lindgardt, President and CEO, will provide a company update and discuss Sera's latest achievements.
- PR Newswire
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that its management team will participate in the following upcoming investor conference:
- Zacks
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates
Sera Prognostics (SERA) delivered earnings and revenue surprises of -8.70% and 70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
